Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 10Brain Neoplasms 3Leukemia, Hairy Cell 2Uveal Melanoma 1Thyroid Neoplasms 1Solid Tumors 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-small Cell Carcinoma 1Neoplasm Metastasis 1Glioma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Craniopharyngioma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

tebentafusp 4Nivolumab 4Magnetic Resonance Spectroscopy 3Cyclophosphamide 3pembrolizumab 2fludarabine phosphate 2fludarabine 2cemiplimab 2Specimen Handling 2Ipilimumab 2Interleukin-2 2sargramostim 1quisinostat 1olaparib 1lifileucel 1binimetinib 1aldesleukin 1aflibercept 1Valproic Acid 1Spinal Puncture 1Protein Kinase C 1Melatonin 1Interleukin-13 1Hematologic Tests 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluorodeoxyglucose F18 1Exercise 1Crizotinib 1Carmustine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Uveal Melanoma × binimetinib × Clear all
NCT03947385 2026-01-27

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

IDEAYA Biosciences

Phase 1/2 Recruiting
336 enrolled
DermatologicGastrointestinal

Uveal Melanoma, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡